Drugs / Bacteriophage OX174
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01617122 | Oct 1995 → Dec 2015 | inborn error of immunity | University of South Florida | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacteriophage OX174 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01617122 ↗ |
| Modality | Vaccine | “Subjects receive bacteriophage vaccinations” NCT01617122 ↗ |
| Route | Intravenous | “Bacteriophage 0X174 is given intravenously” NCT01617122 ↗ |